Mesa Labs to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026
Rhea-AI Summary
Mesa Labs (NASDAQ:MLAB) announced that Gary Owens, President and CEO, and John Sakys, CFO, will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026.
The company will deliver a Formal Presentation at 4:30 p.m. Pacific Time. A live webcast will be accessible via the Events & Presentations section of Mesa Labs' Investor Relations website at https://investors.mesalabs.com/, and an archived replay will be available at the same link after the presentation.
Positive
- None.
Negative
- None.
News Market Reaction – MLAB
In the Dec 19 session, MLAB gained 0.55%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Dec 03 | Earnings date notice | Neutral | +0.4% | Announcement of timing for third quarter fiscal 2026 results release. |
| Nov 12 | Investor conferences | Neutral | -0.2% | Management participation in several investor conferences and related webcasts. |
| Nov 06 | Earnings results | Positive | +0.9% | Q2 FY2026 results with revenue and operating income growth and cost actions. |
| Oct 03 | Earnings date notice | Neutral | +2.9% | Announcement of second quarter FY2026 results release date after market close. |
| Oct 03 | Dividend declaration | Positive | +2.9% | Board declaration of a regular quarterly dividend of $0.16 per share. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent company news has mostly drawn mild positive price reactions, including earnings results and dividend declarations, with one small divergence on a conferences update.
Over the last few months, Mesa Laboratories reported stronger Q2 FY2026 operating results on Nov 6, 2025, with revenue and operating income growth that were followed by a modestly positive price reaction. The company also maintained shareholder returns via a $0.16 quarterly dividend announced on Oct 3, 2025. Multiple earnings‑date and conference participation notices (including in November–December 2025) saw generally small price changes. Today’s J.P. Morgan Healthcare Conference presentation fits this pattern of ongoing investor‑relations outreach rather than a new financial or clinical catalyst.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAKEWOOD, Colo., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today announced that Gary Owens, President and CEO, and John Sakys, CFO will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, 2026. Management will participate in a Formal Presentation at 4:30 p.m. Pacific Time.
A live webcast of the presentation will be accessible here and on the Events & Presentations section of Mesa Lab’s Investor Relations website at https://investors.mesalabs.com/. An archived replay of the webcast will be available through the same link following the presentation.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of life science tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. Mesa offers products and services to help our customers ensure product integrity, increase patient and worker safety, and improve the quality of life throughout the world.
For more information about Mesa, please visit its website at www.mesalabs.com.
Mesa Laboratories Contacts:
Gary Owens; President and CEO,
John Sakys; CFO
1-303-987-8000
investors@mesalabs.com
